Literature DB >> 11784357

Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease.

K A Jellinger1, W Paulus, C Wrocklage, I Litvan.   

Abstract

In order to assess the impact of traumatic brain injury (TBI) and Apolipoprotein E (ApoE) allele frequency on the development of Alzheimer's disease (AD), we examined: (i) the incidence of AD pathology in 55 consecutive autopsy cases (mean age +/- SD 77.6 +/- 7.3 years) with residual closed TBI lesions and (ii) the frequency of TBI residuals in 53 age-matched autopsy proven AD cases. In both series, ApoE was evaluated from archival paraffin-embedded brain material. The results were as follows: (i) In the TBI series, 12.7% showed Consortium to Establish a Registry for Alzheimer's disease (CERAD) definite and 9.1% probable AD, only one with ApoEepsilon4. From the remaining 43 non-AD cases, three had ApoEepsilon4. The prevalence of 21.8% AD in this small autopsy cohort was significantly higher than 3.3% in a recent large clinical series and 14% in the general population over the age of 70. (ii) In the AD cohort with ApoEepsilon4 allele frequency of 30% similar to other AD series, residuals of TBI were seen in 4 brains (7.5%), all lacking the ApoEepsilon4 allele. TBI incidence was slightly higher than 8.5% in the clinical MIRAGE study. The results of this first retrospective autopsy study of TBI, ApoE allele frequency, and AD confirms clinical studies suggesting severe TBI to be a risk factor for the development of AD particularly in subjects lacking ApoEepsilon4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11784357     DOI: 10.1046/j.1468-1331.2001.00322.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  25 in total

Review 1.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

2.  Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.

Authors:  Maya A Koike; Kim N Green; Mathew Blurton-Jones; Frank M Laferla
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  Color changing photonic crystals detect blast exposure.

Authors:  D Kacy Cullen; Yongan Xu; Dexter V Reneer; Kevin D Browne; James W Geddes; Shu Yang; Douglas H Smith
Journal:  Neuroimage       Date:  2010-10-30       Impact factor: 6.556

4.  CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury.

Authors:  Stephanie M Williams; Carrie Peltz; Kristine Yaffe; Philip Schulz; Michael R Sierks
Journal:  Neurology       Date:  2018-10-09       Impact factor: 9.910

Review 5.  Genetics and outcomes after traumatic brain injury (TBI): what do we know about pediatric TBI?

Authors:  Brad Kurowski; Lisa J Martin; Shari L Wade
Journal:  J Pediatr Rehabil Med       Date:  2012

6.  Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.

Authors:  Michael A Sugarman; Ann C McKee; Thor D Stein; Yorghos Tripodis; Lilah M Besser; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Maureen K O'Connor; Rhoda Au; Michael McClean; Ronald Killiany; Jesse Mez; Michael W Weiner; Neil W Kowall; Robert A Stern; Michael L Alosco
Journal:  Alzheimers Dement       Date:  2019-03-07       Impact factor: 21.566

7.  Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.

Authors:  Tiffany F Hughes; Mary Ganguli
Journal:  Curr Psychiatry Rev       Date:  2009-05-01

Review 8.  Inflammation in central nervous system injury.

Authors:  Stuart M Allan; Nancy J Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

9.  Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma.

Authors:  Xiao-Han Chen; Robert Siman; Akira Iwata; David F Meaney; John Q Trojanowski; Douglas H Smith
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

10.  HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats.

Authors:  Bin Zhang; Eric J West; Ken C Van; Gene G Gurkoff; Jia Zhou; Xiu-Mei Zhang; Alan P Kozikowski; Bruce G Lyeth
Journal:  Brain Res       Date:  2008-06-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.